p53 family members in myogenic differentiation and rhabdomyosarcoma development

被引:103
作者
Cam, Hakan
Griesmann, Heidi
Beitzinger, Michaela
Hofmann, Lars
Beinoraviciute-Kellner, Rasa
Sauer, Markus
Huettinger-Kirchhof, Nicole
Oswald, Claudia
Friedl, Peter
Gattenloehner, Stefan
Burek, Christof
Rosenwald, Andreas
Stiewe, Thorsten [1 ]
机构
[1] Univ Wurzburg, Rudolf Virchow Ctr, DFG, Res Ctr Expt Biomed,Mol Tumor Biol Grp, D-97078 Wurzburg, Germany
[2] Univ Wurzburg, DFG, Res Ctr Expt Biomed, Mol Cell Dynam Lab, D-97078 Wurzburg, Germany
[3] Univ Wurzburg, Dept Dermatol, D-97078 Wurzburg, Germany
[4] Univ Wurzburg, Dept Pathol, D-97078 Wurzburg, Germany
关键词
D O I
10.1016/j.ccr.2006.08.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 family comprises the tumor suppressor p53 and the structural homologs p63 and p73. How the three family members cooperate in tumor suppression remains unclear. Here, we report different but complementary functions of the individual members for regulating retinoblastoma protein (RB) function during myogenic differentiation. Whereas p53 transactivates the retinoblastoma gene, p63 and p73 induce the cyclin-dependent kinase inhibitor p57 to maintain RB in an active, hypophosphorylated state. Delta Np73 inhibits these functions of the p53 family in differentiation control, prevents myogenic differentiation, and enables cooperating oncogenes to transform myoblasts to tumorigenicity. Delta Np73 is frequently overexpressed in rhabdomyosarcoma and essential for tumor progression in vivo. These findings establish differentiation control as a key tumor suppressor activity of the p53 family.
引用
收藏
页码:281 / 293
页数:13
相关论文
共 46 条
  • [41] p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours
    Yang, A
    Walker, N
    Bronson, R
    Kaghad, M
    Oosterwegel, M
    Bonnin, J
    Vagner, C
    Bonnet, H
    Dikkes, P
    Sharpe, A
    McKeon, F
    Caput, D
    [J]. NATURE, 2000, 404 (6773) : 99 - 103
  • [42] p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities
    Yang, AN
    Kaghad, M
    Wang, YM
    Gillett, E
    Fleming, MD
    Dotsch, V
    Andrews, NC
    Caput, D
    McKeon, F
    [J]. MOLECULAR CELL, 1998, 2 (03) : 305 - 316
  • [43] pRb controls proliferation differentiation, and death of skeletal muscle cells and other lineages during embryogenesis
    Zacksenhaus, E
    Jiang, Z
    Chung, D
    Marth, JD
    Phillips, RA
    Gallie, BL
    [J]. GENES & DEVELOPMENT, 1996, 10 (23) : 3051 - 3064
  • [44] Oncogenes induce and activate endogenous p73 protein
    Zaika, A
    Irwin, M
    Sansome, C
    Moll, UM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) : 11310 - 11316
  • [45] ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors
    Zaika, AI
    Slade, N
    Erster, SH
    Sansome, C
    Joseph, TW
    Pearl, M
    Chalas, E
    Moll, UM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) : 765 - 780
  • [46] p21CIP1 and p57KIP2 control muscle differentiation at the myogenin step
    Zhang, PM
    Wong, C
    Liu, D
    Finegold, M
    Harper, JW
    Elledge, SJ
    [J]. GENES & DEVELOPMENT, 1999, 13 (02) : 213 - 224